However, gut microbiota alterations have been shown to influence incretin sensitivity in obesity, insulin resistance, and T2D [28,29]; therefore, elevated GLP-1 and GIP levels may be reflective of a compensatory response that ultimately fails to promote β-cell function. Here, GIP is linked to obesity due to melanocortin 4 receptor deficiency.